Evidence map›Paper›PMID 40522381›Full record

ArticleMolecular neurobiology2025

Serotonergic Regulation of Photic Signaling of Ascorbate in the Rat Thalamus.

Hiroyuki Miyamoto, Kozo Hamada

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiroyuki MiyamotoDepartment of Biomedical Chemistry, Institute of International Health, The University of Tokyo Graduate School of Medicine, Bunkyo-Ku, Tokyo, 113-0033, Japan.ORCID http://orcid.org/0000-0002-5388-8053
Kozo HamadaDepartment of Biomedical Chemistry, Institute of International Health, The University of Tokyo Graduate School of Medicine, Bunkyo-Ku, Tokyo, 113-0033, Japan. Kozo.Hamada@xjtlu.edu.cn.ORCID http://orcid.org/0000-0002-2795-802X

Funding

Japan Society for the Promotion of Science 21K06379the Research Development Fund (RDF) supported by XJTLU RDF-24-01-007
6 · The paper itself

Abstract

Ascorbate, a potent reducing agent highly concentrated in the brain, prevents neuronal oxidative damage and functions as a neuromodulator. Disrupted ascorbate homeostasis has been linked to neurological disorders, including Alzheimer's disease. However, the in vivo mechanisms regulating brain ascorbate levels remain largely unexplored. Here, we demonstrate that serotonin and photic signaling jointly modulate extracellular ascorbate levels in the rat brain. Using in vivo microdialysis, we observed circadian rhythms in both serotonin metabolites and ascorbate levels in the thalamus of freely moving rats. Ascorbate exhibited marked photosensitivity, decreasing under light exposure and recovering in darkness. Serotonin depletion disrupted these circadian rhythms and abolished ascorbate's photosensitivity. These findings suggest that brain ascorbate dynamics are regulated by both serotonergic activity and environmental light, highlighting a novel interplay between neural signaling and redox systems in the thalamus.

Indexed as

Ascorbic AcidLightLight Signal TransductionSerotoninSignal TransductionThalamusAnimalsCircadian RhythmMaleRatsRats, Sprague-DawleyAscorbic AcidSerotoninAscorbateCircadian rhythmPhotic signalingSerotoninThalamusTryptophan

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.